iVoice, Inc., Announces Record Date for Spin-Off of Thomas Pharmaceuticals Ltd. To Shareholders
21:35 08.11.07
Fifth Spin-Off and Fifth Stock Dividend to the Shareholders
MATAWAN, N.J.--(BUSINESS WIRE)--iVoice, Inc. (OTC Bulletin Board: IVOI), announced today the record date
of November 14, 2007 for the pending spin-off in the form of a special
dividend of its wholly owned subsidiary, Thomas Pharmaceuticals Ltd. (Thomas
Pharmaceuticals).
Each iVoice shareholder of record as of November 14 2007 will receive
shares of Thomas Pharmaceuticals. In order to receive shares in
Thomas Pharmaceuticals, you must own shares of iVoice, Inc. on the
record date of November 14, 2007. It is anticipated that the
distribution in the form of a special dividend of Thomas Pharmaceuticals
shares will occur sometime in November 2007. Following the distribution,
Thomas Pharmaceuticals plans to have its shares traded on the NASD OTC
Bulletin Board. Each holder of iVoice Class A Common Stock, except for
certain affiliates, will receive one share of Thomas Pharmaceuticals,
Ltd. Class A Common Stock for each share of iVoice Class A Common Stock
held.
The Company revised the record date for the distribution of the Thomas
Pharmaceuticals spin-off to November 14, 2007 to permit the Company to
register additional shares with the Securities and Exchange Commission
to reflect the recent increase in the number of outstanding shares of
iVoice as a result of a conversion by a holder of an outstanding
convertible debenture to Class A Common Stock of iVoice.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value,
separate and apart from the operating performance of iVoice, is to
implement new business opportunities by distributing shares of spin-offs
to the Company's shareholders. The common stock distributions are part
of a broader strategy relating to the transition of iVoice into a
company focused on the development and licensing of proprietary
technologies. We also continue to search for potential merger candidates
with or without compatible technology and products, which management
feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain
forward-looking statements about our current and expected performance
trends, growth plans, business goals and other matters. These statements
may be contained in our filings with the Securities and Exchange
Commission, in our press releases, in other written communications, and
in oral statements made by or with the approval of one of our authorized
officers. Information set forth in this press release contains various
"forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. The Private Securities Litigation Reform Act of 1995 (the "Act")
provides certain "safe harbor" provisions for forward-looking
statements. The reader is cautioned that such forward-looking statements
are based on information available at the time and/or management's good
faith belief with respect to future events, and are subject to risks and
uncertainties that could cause actual performance or results to differ
materially from those expressed in the statements. Forward-looking
statements speak only as of the date the statement was made. We assume
no obligation to update forward-looking information to reflect actual
results, changes in assumptions or changes in other factors affecting
forward-looking information. Forward-looking statements are typically
identified by the use of terms such as "anticipate," "believe," "could,"
"estimate," "expect," "intend," "may," "might," "plan," "predict,"
"project," "should," "will," and similar words, although some
forward-looking statements are expressed differently. Although we
believe that the expectations reflected in such forward-looking
statements are reasonable, we can give no assurance that such
expectations will prove to be correct.
For more information on iVoice, please visit www.ivoice.com